编者按：第24届亚洲胸心外科协会（ASCVTS）暨第4届亚洲单孔胸腔镜论坛（ASPVS）于2016年4月6-10日在台北国际会议中心举行。正式大会在4月4月8日开幕，前两天会议分别为海峡两岸交流会和 AATS postgraduate course。
本次会议云集了胸心外科领域的国际重量级专家，其中不乏中国讲者的身影，活跃于会场间。如先前微信报道的，秉承着快乐学术、促进交流的会议报道宗旨，AME 出版社以展台为线下基地，在会议期间展开了一场 “East meets West, junior meets Senior, KOL meets KOL(key opinion leader)” 等对话运动，邀请国内外优秀医师、国际学科意见领袖等就相关热点话题进行访谈对话。
Prof. Calvin Ng对话张兰军教授
1. After NLST study, LDCT screening is more and more frequently applied in Asian countries. In some observational studies, SPN can be detected in 10-15% screening cases. Could you share with us your strategies to deal with them?
2. VATS has become one of the most popular approaches to sublobar resection. It can bring many benefits to the patients, while there are some unpleasant experiences for surgeons. Specifically, it is difficult for palpation during the operation. Would you please share some tips about the identity of peripheral SPN?
Calvin Sze Hang Ng, BSc(Hons), MBBS(Hons), MD(Res)(Lond), FRCSEd(CTh), FCSHK, FHKAM(Surg), FCCP
Dr Ng is an Associate Professor in Cardiothoracic Surgery at Prince of Wales Hospital, The Chinese University of Hong Kong. He is a pioneer in Single Port (Uniportal) VATS in the Asia-Pacific region with numerous publications on the subject in JTCVS, EJCTS, ICVTS, CHEST and Thorax, amongst other journals. He is the Founder of the Asian Single Port VATS Symposium series, and President of Asian Association for Single Port Thoracic Surgery.
Lanjun Zhang, MD, PhD,Department of Thoracic Surgery, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China
Professor Zhang focuses his study either on clinical or basic research, including lung cancer, esophageal cancer, tumor biomarkers investigation, Prognostic factors and treatment stratification, and target therapy. He is also an expert in the reconstruction with artificial bio-materials organs. The patent of his artificial esophagus was awarded in 2001. He is also involved in numerous review committees of journals, funds and diverse expertise in China and internationally.